Estradiol supplementation modulates growth hormone (GH) secretory-burst waveform and recombinant human insulin-like growth factor-I-enforced suppression of endogenously driven GH release in postmenopausal women.
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
The present study tests the mechanistic postulate that estrogen confers resistance to negative feedback by systemic IGF-I. To this end, eight postmenopausal women received a constant iv infusion of recombinant human (rh)IGF-I (10 micro g/kg.h x 6 h) and saline in randomized order on the 10th day of supplementation with oral estradiol (E(2)) and placebo (Pl). GH secretion was quantitated by 10-min blood sampling, immunochemiluminometry assay, and deconvolution analysis. Administration of E(2) compared with Pl followed by saline infusion: 1) stimulated pulsatile GH secretion ( micro g/liter.6 h), viz., 12 +/- 3.3 (Pl) and 18 +/- 4.6 (E(2)) (mean +/- SEM, paired comparison, P < 0.05); 2) halved the time latency (min) to achieve peak GH secretion after GHRH injection, 24 +/- 2.2 (Pl) and 12 +/- 2.1 (E(2)) (P < 0.01); and 3) did not alter the mass of GH secreted ( micro g/liter) in response to a maximally effective dose of GHRH, 30 +/- 7.2 (Pl) and 37 +/- 11 (E(2)). Exposure to E(2) compared with Pl followed by rhIGF-I infusion: 1) accelerated the rate of decline of GH concentrations by 3.3-fold, viz., absolute slope ( micro g/liter.1000 min), 3.8 (range, 2.5-5.0) (Pl) and 12 (range, 10-14) (E(2)) (P < 0.001); 2) augmented the algebraic decrement in GH concentrations ( micro g/liter) enforced by rhIGF-I infusion, 0.73 +/- 0.21 (Pl) and 1.6 +/- 0.25 (E(2)) (P < 0.01); 3) halved the time delay (min) to peak GHRH-induced GH secretion, 20 +/- 1.2 (Pl) vs. 10 +/- 1.3 (E(2)) min (P < 0.01). In contradistinction, E(2) did not alter: 1) the capability of rhIGF-I to suppress GHRH-stimulated GH secretory burst mass significantly, viz., by 50 +/- 8% (Pl) and 52 +/- 14% (E(2)) (P < 0.05 each vs. saline); 2) the hourly rate of rise of infused (total) IGF-I concentrations; and 3) total and ultrafiltratably free IGF-I concentrations ( micro g/liter) attained at the end of the two rhIGF-I infusions. In summary, compared with Pl, E(2) supplementation in postmenopausal women: 1) amplifies endogenously driven GH secretory-burst mass; 2) initiates rapid onset of GHRH-stimulated GH release; and 3) potentiates IGF-I-dependent suppression of unstimulated GH concentrations. Based upon companion modeling data, we postulate that E(2) facilitates the upstroke and IGF-I enforces the downstroke of high-amplitude GH secretory bursts in estrogen-replete individuals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Equivalent basal GH secretion in a low and high E 2 milieu indicates that E 2 is not a primary determinant of nonpulsatile GH secretion in the human (1,39).”
From Determinants of dual secretagogue drive of burst-like growth hormone secretion in premenopausal women studied under a selective estradiol clamp (2005) · cites this paper as [39]
In the citing paper
“clinical investigations indicate that E 2 supplementation in postmenopausal women augments stimulation by GHRP-2 and submaximal drive by GHRH”
From Determinants of dual secretagogue drive of burst-like growth hormone secretion in premenopausal women studied under a selective estradiol clamp (2005) · cites this paper as [39]
Citations
Cites
Giustina, A., & Veldhuis, J. D. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0353 · Cited by 1,253 · cited 3×
“progestin) via oral, higher-dose transdermal, iv, intranasal, im, or intravaginal routes can reduce total IGF-I concentrations in hypogonadal girls and women, male-to-female transsexual patients, and men with prostatic carcinoma (1, 18).”
BackgroundSelf-citationNeuroendocrine Control of Growth Hormone Secretion
Müller, E. E., Locatelli, V., & Cocchi, D. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.2.511 · Cited by 634
Veldhuis, J. D. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.11.3209 · Cited by 389
Self-citationReceptor-Mediated Peptide Transport through the Blood-Brain Barrier*
PARDRIDGE, W. M. (1986) · Endocrine Reviews · doi:10.1210/edrv-7-3-314 · Cited by 313 · cited 1×
“Because systemic estrogens and intact insulinomimetic peptides have access to the hypothalamus and pituitary gland (1, 8, 33), available data do not allow unique localization of the site(s) of interaction of IGF-I and estrogen in mediating enhanced negative feedback, as observed here.”
BackgroundFree insulin‐like growth factors (IGF‐I and IGF‐II) in human serum
Frystyk, J., Skjærbæk, C., Dinesen, B., & Ørskov, H. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00602-4 · Cited by 306
Self-citationYAMASHITA, S., & MELMED, S. (1986) · Endocrinology · doi:10.1210/endo-118-1-176 · Cited by 265
Regulatory mechanisms of growth hormone secretion are sexually dimorphic.
Jaffe, C. A., Ocampo-Lim, B., Guo, W., Krueger, K., Sugahara, I., DeMott-Friberg, R., Bermann, M., & Barkan, A. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2908 · Cited by 236 · cited 1×
“In one comparison by gender, constant iv infusion of rhIGF-I for 24 h: 1) elevated IGF-I concentrations more in women than men (mean absolute difference, 300 g/liter); 2) decreased GH concentrations more in women than men in the daytime awake fed state but did the opposite during overnight sleep when fasting; and 3) i…”
BackgroundHartman, M. L., Clayton, P. E., Johnson, M. L., Celniker, A., Perlman, A. J., Alberti, K. G., & Thorner, M. O. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116480 · Cited by 192
FARIA, A. C. S., VELDHUIS, J. D., THORNER, M. O., & VANCE, M. L. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-3-535 · Cited by 147 · cited 1×
“Basal (nonpulsatile) GH secretion was estimated by waveform-independent deconvolution analysis assuming a priori biexponential kinetics (23, 24).”
MethodSelf-citationA feedback-controlled ensemble model of the stress-responsive hypothalamo-pituitary-adrenal axis.
Keenan, D. M., Licinio, J., & Veldhuis, J. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051624198 · Cited by 145 · cited 3×
“Pulsatile GH secretion was quantitated by a recently validated deconvolution procedure (25, 26).”
BackgroundMethodSelf-citation
Cited by
Endocrine Control of Body Composition in Infancy, Childhood, and Puberty
Veldhuis, J. D., Roemmich, J. N., Richmond, E. J., Rogol, A. D., Lovejoy, J. C., Sheffield-Moore, M., Mauras, N., & Bowers, C. Y. (2005) · Endocrine Reviews · doi:10.1210/er.2003-0038 · Cited by 452
Self-citationSomatotropic and Gonadotropic Axes Linkages in Infancy, Childhood, and the Puberty-Adult Transition
Veldhuis, J. D., Roemmich, J. N., Richmond, E. J., & Bowers, C. Y. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0006 · Cited by 236
Self-citationMakrantonaki, E., Vogel, K., Fimmel, S., Oeff, M. K., Seltmann, H., & Zouboulis, C. C. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.07.005 · Cited by 103
Skin and brain age together: The role of hormones in the ageing process
Makrantonaki, E., Schönknecht, P., Hossini, A. M., Kaiser, E., Katsouli, M.-M., Adjaye, J., Schröder, J., & Zouboulis, C. C. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.08.005 · Cited by 94
“Supplementation of middle-aged and older men with high-dose testosterone attenuated IGF-I feedback-dependent inhibition of GH secretion (Veldhuis et al., 2004), whereas the acute administration of estradiol accentuated IGF- I-induced inhibition of GH secretion (Veldhuis et al., 2004).”
InfluentialChen, J., Højlund, K., Beck‐Nielsen, H., Christiansen, J. S., Ørskov, H., & Frystyk, J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0039 · Cited by 73
Self-citationStokes, K., Nevill, M. E., Frystyk, J., Lakomy, H. K. A., & Hall, G. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00839.2004 · Cited by 57
“Conversely, circulating IGF-I (in particular free IGF-I) may participate in the feedback control of GH secretion (7) at various levels: IGF-I increases somatostatin and reduces GH-releasinghormone synthesis and secretion in the hypothalamus, and inhibits GH synthesis and release in the pituitary (2, 6, 16, 17, 20, 44).”
BackgroundSelf-citationVeldhuis, J. D., Frystyk, J., Iranmanesh, A., & Ørskov, H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1314 · Cited by 54
“The effect of GHRH on GH secretion in these two studies was reported earlier (36, 37).”
BackgroundMethodSelf-citationVeldhuis, J. D., Keenan, D. M., Mielke, K., Miles, J. M., & Bowers, C. Y. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02001 · Cited by 35
“This point is significant, because estradiol supplementation in postmenopausal women nearly doubles maximal stimulation by GHRP-2, albeit not by recombinant human GHRH-1,44-amide (21, 22, 28 ).”
BackgroundSelf-citationEstradiol Potentiates Ghrelin-Stimulated Pulsatile Growth Hormone Secretion in Postmenopausal Women
Veldhuis, J. D., Keenan, D. M., Iranmanesh, A., Mielke, K. L., Miles, J. M., & Bowers, C. Y. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0948 · Cited by 35
“The principal analytical outcomes are pulsatile GH secretion (micrograms per liter per 3 h), defined as the summed mass of GH secreted in bursts after saline or secretagogue infusion, and the modal time latency (minutes) to achieve maximal secretion within any given burst (12, 13, 44).”
BackgroundSelf-citationSex-steroid control of the aging somatotropic axis
Veldhuis, J. D., Erickson, D., Iranmanesh, A., Miles, J. M., & Bowers, C. Y. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.07.006 · Cited by 30
Self-citationChaves, F. M., Wasinski, F., Tavares, M. R., Mansano, N. D. S., Frazão, R., Gusmão, D. O., Quaresma, P. G. F., Pedroso, J. A. B., Elias, C. F., List, E. O., et al. (2022) · Endocrinology · doi:10.1210/endocr/bqac045 · Cited by 32
Veldhuis, J. D., Anderson, S. M., Iranmanesh, A., & Bowers, C. Y. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1303 · Cited by 27
“A parallel earlier feedback analysis in healthy postmenopausal women disclosed that acute (10 d) administration of E2 paradoxically accentuates rh IGF-I-induced inhibition of GH secretion (9).”
BackgroundSelf-citationErickson, D., Keenan, D. M., Mielke, K., Bradford, K., Bowers, C. Y., Miles, J. M., & Veldhuis, J. D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0424 · Cited by 26
Self-citationCosma, M., Bailey, J. N., Miles, J. M., Bowers, C. Y., & Veldhuis, J. D. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1322 · Cited by 27
Self-citationVeldhuis, J. D., Erickson, D. Z., Mielke, K. L., Farhy, L. S., Keenan, D. M., & Bowers, C. Y. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0854 · Cited by 26
Self-citationErickson, D., Keenan, D. M., Farhy, L., Mielke, K., Bowers, C. Y., & Veldhuis, J. D. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1621 · Cited by 21
“Conversely, elevation of IGF-I concentrations into the late-pubertal range by constant iv infusion of this peptide suppresses GH secretion by more than 65% (39, 43).”
BackgroundMethodSelf-citationvan der Klaauw, A. A., Biermasz, N. R., ZELISSEN, P. M. J., Pereira, A. M., Lentjes, E. G. W. M., Smit, J. W. A., van Thiel, S. W., Romijn, J. A., & Roelfsema, F. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0412 · Cited by 21
Quinnies, K. M., Bonthuis, P. J., Harris, E. P., Shetty, S. R. J., & Rissman, E. F. (2015) · Biology of Sex Differences · doi:10.1186/s13293-015-0026-x · Cited by 18
“Secretion of GH from the pituitary is pulsatile throughout the day [3-5]; therefore, we speculate that GH may be likewise produced and released via an ultradian rhythm.”
BackgroundVilla, P., Costantini, B., Perri, C., Suriano, R., Ricciardi, L., & Lanzone, A. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.02.042 · Cited by 19
Veldhuis, J. D., Weltman, J. Y., WELTMAN, A. L., Iranmanesh, A., Müller, E. E., & Bowers, C. Y. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0282 · Cited by 17
Self-citationRoelfsema, F., Yang, R. J., Takahashi, P. Y., Erickson, D. Z., Bowers, C. Y., & Veldhuis, J. D. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00755 · Cited by 16
Self-citationAcute resistance exercise stimulates sex-specific dimeric immunoreactive growth hormone responses
Luk, H. Y., Kraemer, W. J., Szivak, T. K., Flanagan, S. D., Hooper, D. R., Kupchak, B. R., Comstock, B. A., Dunn‐Lewis, C., Vingren, J. L., DuPont, W. H., et al. (2015) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2015.02.002 · Cited by 14
Yan, M., Jones, M. E. E., Hernández, M. I., Liu, D., Simpson, E. R., & Chen, C. (2005) · Neuroendocrinology · doi:10.1159/000086864 · Cited by 13
Veldhuis, J. D., Keenan, D. M., Bailey, J. N., Adeniji, A., Miles, J. M., Paulo, R., Cosma, M., & Soares-Welch, C. V. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1493 · Cited by 11
Self-citationLe traitement hormonal des patients transsexuels et ses conséquences métaboliques
Corman, V., & Legros, J. (2007) · Annales d Endocrinologie · doi:10.1016/j.ando.2007.06.017 · Cited by 8
Fintini, D., Alba, M., & Salvatori, R. (2005) · Experimental Biology and Medicine · doi:10.1177/153537020523001004 · Cited by 8
Model-Based Evaluation of Growth Hormone Secretion
Veldhuis, J. D., & Keenan, D. M. (2012) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-381272-8.00014-3 · Cited by 7
Self-citationThe effects of sex steroid replacement therapy on an expanded panel of IGF-related peptides
Renehan, A. G., Frystyk, J., Howell, A., O’Dwyer, S., Shalet, S. M., & Flyvbjerg, A. (2007) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2007.01.017 · Cited by 7
“As free IGF-I is the key negative feedback to pituitary secretion of GH [36], consistent with this hypothesis, oral estrogen administration (through reduction in free IGF-I) is associated with increased circulating GH levels, and indeed, has been shown to amplify endogenously driven GH secretoryburst activity [37].”
BackgroundSelf-citationKanaley, J. A., Giannopoulou, I., Collier, S. R., Ploutz-Snyder, R. J., & Carhart, R. L. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02006 · Cited by 7
The estrogenic component of tibolone reduces adiposity in female aromatase knockout mice
Sinderen, M. L. V., Boon, W. C., EDERVEEN, A. G. H., Kloosterboer, H. J., Simpson, E. R., & Jones, M. E. E. (2009) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31818fb20b · Cited by 4
“The effects of additional androgens and progestogens on the pituitary have not yet been examined, although it is believed that androgens increase GH only indirectly through aromatization to estrogen.(33,34) Although it has been reported that tibolone or transdermal estrogen administration in postmenopausal women could…”
BackgroundVeldhuis, J. D., Yang, R. J., Wigham, J. R., Erickson, D. Z., Miles, J. C., & Bowers, C. Y. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2633 · Cited by 2
“Analogously, E2 and IGF-I are synergistic in promoting neurite outgrowth and uterine epithelial proliferation and disinhibitory of GH secretion (34, 35).”
BackgroundSelf-citationDeconvolution as a Novel Approach to Analyze Moment‐to‐Moment Free Fatty Acid Release
Hücking, K., Hsu, I. R., Ionut, V., & Bergman, R. N. (2007) · Obesity · doi:10.1038/oby.2007.287 · Cited by 3
“Deconvolution has also been used extensively to determine secretory rates of various pulsatile endocrine hormones, such as leuteinizing hormone secretion (20), growth hormone secretion (21,22), and in vivo and in vitro insulin release (23,24).”
MethodUtility of Ultrasensitive Growth Hormone Assays in Assessing Aging-Related Hyposomatotropism
Iranmanesh, A., & Veldhuis, J. D. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.07.005 · Cited by 1
Self-citationFigueiredo, P. R. L., Martins, M. R. A., Montenegro, R. M., Albano, M. F., & Montenegro, R. M. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000800018 · Cited by 3
Metadata
- Authors
- Veldhuis, J. D., Anderson, S. M., Kok, P., Iranmanesh, A., Frystyk, J., Ørskov, H., & Keenan, D. M.
- Affiliations
- Mayo Clinic (US)
- Leiden University Medical Center (NL)
- Salem VA Medical Center (US)
- Aarhus University Hospital (DK)
- University of Virginia (US)
- Corresponding author
- Veldhuis, Johannes D.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-03
- Volume
- 89
- Issue
- 3
- Pages
- 1312-1318
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2004053614
- Semantic Scholar
- fed355828e7e41b6b3e93118398a4b551a460548
- Cited by
- 34
- References
- 36
- Citations by year
- 2022: 1 · 2018: 1 · 2015: 2 · 2014: 1 · 2012: 1
- FWCI
- 4.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsches Krebsforschungszentrum
- National Institute on Aging (K01 AG-19164, R01 NIA AG 14799, K01AG019164)
- National Center for Research Resources (RR-00585, M01RR000847, M01RR000585, M01-RR 00847)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- estradiol, growth hormone secretion, insulin-like growth factor I, negative feedback, IGF-I resistance, postmenopausal women, GHRH stimulation, deconvolution, pulsatility index
- MeSH terms
- Drug Interactions, Estradiol, Female, Humans, Insulin-Like Growth Factor I, Middle Aged, Models, Biological, Phosphorus, Potassium, Prospective Studies, Pulsatile Flow, Recombinant Proteins, Postmenopause, Human Growth Hormone, Feedback, Physiological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.